Accounting fordropout inxenografted tumour efficacy studies: integrated endpoint analysis, reduced bias andbetter use ofanimals
| dc.contributor.author | C.Martin, Emma | |
| dc.date.accessioned | 2020-02-11T07:14:08Z | |
| dc.date.accessioned | 2021-10-20T14:57:28Z | |
| dc.date.accessioned | 2024-06-27T15:34:09Z | |
| dc.date.available | 2020-02-11T07:14:08Z | |
| dc.date.available | 2021-10-20T14:57:28Z | |
| dc.date.available | 2024-06-27T15:34:09Z | |
| dc.date.issued | 2016-09 | |
| dc.identifier.uri | https://drs.ess.gov.et/handle/123456789/105394 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Science+Business Media, LLC | en_US |
| dc.subject | Dropout· Joint models· Xenograft· Tumour growth models | en_US |
| dc.title | Accounting fordropout inxenografted tumour efficacy studies: integrated endpoint analysis, reduced bias andbetter use ofanimals | en_US |
| dc.type | Article | en_US |